(19)
(11) EP 2 857 840 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
02.08.2017 Bulletin 2017/31

(45) Mention of the grant of the patent:
14.06.2017 Bulletin 2017/24

(21) Application number: 15150111.1

(22) Date of filing: 18.07.2007
(27) Previously filed application:
 18.07.2007 EP 10162987
(51) International Patent Classification (IPC): 
G01N 33/68(2006.01)

(54)

Method for predicting implantation success in assisted fertilisation

Verfahren zur Vorhersage des Implantationserfolgs bei der assistierten Befruchtung

Procédé pour prédire le succès d'implantation dans la fécondation assistée


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 21.07.2006 US 832094 P

(43) Date of publication of application:
08.04.2015 Bulletin 2015/15

(60) Divisional application:
17175527.5

(62) Application number of the earlier application in accordance with Art. 76 EPC:
10162987.1 / 2214021
07787688.6 / 2049906

(73) Proprietor: Femalon S.P.R.L.
4460 Grâce-Hollogne (BE)

(72) Inventors:
  • Lédée, Nathalie
    75010 Paris (FR)
  • Piccinni, Marie-Pierre
    50134 Florence (IT)
  • Lombroso, Raoul
    78300 Poissy (FR)

(74) Representative: Gyi, Jeffrey Ivan et al
De Clercq & Partners Edgard Gevaertdreef 10 a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)


(56) References cited: : 
   
  • SALMASSI A ET AL: "Is granulocyte colony-stimulating factor level predictive for human IVF outcome?", HUMAN REPRODUCTION (OXFORD), vol. 20, no. 9, September 2005 (2005-09), pages 2434-2440, XP002453576, ISSN: 0268-1161
  • SALMASSI A ET AL: "Success of COH and IVF correlated with granulocyte-colony-stimulating factor", HUMAN REPRODUCTION (OXFORD), vol. 21, no. Suppl. 1, June 2006 (2006-06) , page I159, XP002453577, & 22ND ANNUAL MEETING OF THE EUROPEAN-SOCIETY-OF-HUMAN-REPRODUCTION-AND EMBRYOLOGY; PRAGUE, CZECH REPUBLIC; JUNE 18 -21, 2006 ISSN: 0268-1161
  • GIAVEDONI L D: "Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 301, no. 1-2, June 2005 (2005-06), pages 89-101, XP004976653, ISSN: 0022-1759
  • YANAGI K ET AL: "Cyclic changes of granulocyte colony-stimulating factor (G-CSF) mRNA in the human follicle during the normal menstrual cycle and immunolocalization of G-CSF protein.", HUMAN REPRODUCTION (OXFORD), vol. 17, no. 12, December 2002 (2002-12), pages 3046-3052, XP002453578, ISSN: 0268-1161
  • WANG J: "Proteomic identification of inflammatory markers in cerebrospinal fluid from infectious and non - infectious human brain diseases.", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol. 2003, 2003, XP002453579, & 33RD ANNUAL MEETING OF THE SOCIETY OF NEUROSCIENCE; NEW ORLEANS, LA, USA; NOVEMBER 08-12, 2003
  • SALMASSI ALI ET AL: "Detection of granulocyte colony-stimulating factor and its receptor in human follicular luteinized granulosa cells.", FERTILITY AND STERILITY, vol. 81, no. Suppl. 1, March 2004 (2004-03), pages 786-791, XP008084388, ISSN: 0015-0282
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).